Changes in Innate and Permissive Immune Responses after HBV Transgenic Mouse Vaccination and lLong-Term-siRNA Treatment

BACKGROUND: Currently, no licensed therapy can thoroughly eradicate hepatitis B virus (HBV) from the body, including interferon α and inhibitors of HBV reverse-transcription. Small interfering RNA (siRNA) seem to be a promising tool for treating HBV, but had no effect on the pre-existing HBV covalen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Guang-Li, Huang, Guang-Yu, Zheng, Hong, Fang, Ying, Ma, Heng-Hao, Xu, Man-Chun, Zhang, Hong-Bin, Zhang, Wei-Yun, Zhao, Ya-Gang, Sun, Da-Yong, Hu, Wen-Kui, Liu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589400/
https://www.ncbi.nlm.nih.gov/pubmed/23472088
http://dx.doi.org/10.1371/journal.pone.0057525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589400/
https://www.ncbi.nlm.nih.gov/pubmed/23472088
http://dx.doi.org/10.1371/journal.pone.0057525

Ejemplares similares